Meta-Analysis
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jul 14, 2019; 25(26): 3450-3467
Published online Jul 14, 2019. doi: 10.3748/wjg.v25.i26.3450
Table 1 Characteristics of studies of molecular analysis included in the analysis
Ref.Type of studyNumber of genes/DNA quantity, ng/microLDiagnosisSample sizeTechnical successAdverse eventsDiagnostic yieldSurgical cohortMean cyst size and range (mm)Cysts < 3 cmCyst locationSpecific Cyst DiagnosisSpecific Cyst DiagnosisHigh risk cystsMucinous low-risk cystsBenign cystsSpecific cyst type (MA/surgical pathology)
(study period)(mean and interval)(all patients in the study)(successful molecular analysis)(major/minor)(patients with DNA mutations detected)(H/B/T)Cysts with mutations(MA/all patients)(MA/surgical pathology)(MA/surgical pathology)(MA/surgical pathology)(MA/surgical pathology)IPMN-ADCIPMN-HGIPMN-LGMCN-HGMCN-LGSCAPseudocystNETOther4
Jones et al[45], 2015Prospective (Mar 2013-Feb 2014)39/12.3 (0-1283)Pathology or cytology8679 (only 3 due to NGS failure)NA4610NANANA72/925/101/64/40/01/40/24/40/00/00/00/00/00/0
Singhi et al[46], 2016Retrospective (Jan 2014-May 2015)6/NAPathology or clinicopathologic225225NA118412.8 (8-115)15295/81/49130/22532/4110/1412/1310/149/921/2212/120/00/12/28/80/20/53
Rosenbaum et al[32], 2016Retrospective (Mar 2013-Jun 2015)9/NAPathology or clinicopathologic105105NA6725NANANA67/1131NANANANANANANANANANANANANA
Singhi et al[47], 2017Prospective (Jan 2014-Ju 2017)11/6.93 (0.01-248)Pathology or cytology642595NA3351022.7 (8-210)NA320/B+T=306357/62677/10217/2941/4719/2613/134/4339/390/22/82/317/170/90/73
10581004NA566 (54%)1782,7(8-210)152828/965 (86%)114/153 (74%)28/49 (62%)57/64 (89%)29/40 (73%)23/265/855/550/22/94/525/250/110/12